The in vivo studies using pancreatic cancer CDX models revealed that doses of HuNbTROP2-HSA-MMAE at 0.2 mg/kg and 1 mg/kg achieved notable antitumor effects, with complete tumor eradication achieved at a dose of 5 mg/kg. This evidence concerns the gene ALB and neoplasm.